Drug companies can't rely on blockbusters for much longer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1416, 2003-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non‐invasive diagnosis of pink basal cell carcinoma: how much can we rely on dermoscopy and reflectance confocal microscopy?

By  

SKIN RESEARCH AND TECHNOLOGY, Vol. 22, Iss. 2, 2016-05 ,pp. : 230-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunity

By Nucci Gianluca   Gomeni Roberto   Poggesi Italo  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 8, 2009-08 ,pp. : 837-856

Informa Healthcare

Access to resources Recommend Favorite

Can Drug Users be Effective Change Agents??? Yes, But Much Still Needs to Change

By Dickson-Gomez Julia  

Substance Use & Misuse, Vol. 45, Iss. 1-2, 2010-01 ,pp. : 154-160

Informa Healthcare

Access to resources Recommend Favorite

Patients with psoriasis can't get no satisfaction from systemic therapies

By  

Inpharma, Vol. 1, Iss. 1486, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

We Have a New Treatment, But You Can't Afford It

By Desch Christopher E.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 8, 2006-09 ,pp. : 720-723

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite